Starpharma Holdings Ltd has released a press release.
Starpharma announces new CEO, Ms Cheryl Maley
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Starpharma receives $7.2 million R&D Tax Incentive refund
- Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer
- DEP irinotecan clinical data presented at AACR meeting
- DEP irinotecan combination data presentation
- VIRALEZ UK COVID-19 Clinical Study Completes Recruitment
Later from Starpharma
- AGM Chairman's address and CEO presentation
- Positive DEP docetaxel Phase 2 results
- VivaGel BV sales and distribution agreement MENA region
- Viraleze shows antiviral efficacy in COVID-19 patients
- VivaGel BV US FDA Appeal Outcome
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma